LPI-1503

N/A

Report date: 2026/03/30 20:02:02

Base Information

Drug NameLPI-1503
Drug Alias NameOndansetron Inhalation Powder (Luxena Pharmaceuticals)LPI-1503
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsPostoperative Nausea and Vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLuxena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLuxena Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPostoperative Nausea and Vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A